HEADER TRANSFERASE/INHIBITOR 15-AUG-23 8TU3 TITLE BRUTON'S TYROSINE KINASE IN COMPLEX WITH COVALENT INHIBITOR COMPOUND TITLE 2 10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN RESIDUES 382-659; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.M.METRICK REVDAT 1 26-JUN-24 8TU3 0 JRNL AUTH M.K.HIMMELBAUER,B.BAJRAMI,R.BASILE,A.CAPACCI,T.CHEN, JRNL AUTH 2 C.K.CHOI,R.GILFILLAN,F.GONZALEZ-LOPEZ DE TURISO,C.GU, JRNL AUTH 3 M.HOEMBERGER,D.S.JOHNSON,J.H.JONES,E.KADAKIA,M.KIRKLAND, JRNL AUTH 4 E.Y.LIN,Y.LIU,B.MA,T.MAGEE,S.MANTENA,I.E.MARX,C.M.METRICK, JRNL AUTH 5 M.MINGUENEAU,P.MURUGAN,C.A.MUSTE,P.NADELLA,M.NEVALAINEN, JRNL AUTH 6 C.R.PARKER HARP,V.PATTAROPONG,A.PIETRASIEWICZ,R.J.PRINCE, JRNL AUTH 7 T.J.PURGETT,J.C.SANTORO,J.SCHULZ,S.SCIABOLA,H.TANG, JRNL AUTH 8 H.G.VANDEVEER,T.WANG,Z.YOUSAF,C.J.HELAL,B.T.HOPKINS JRNL TITL DISCOVERY AND PRECLINICAL CHARACTERIZATION OF BIIB129, A JRNL TITL 2 COVALENT, SELECTIVE, AND BRAIN-PENETRANT BTK INHIBITOR FOR JRNL TITL 3 THE TREATMENT OF MULTIPLE SCLEROSIS. JRNL REF J.MED.CHEM. V. 67 8122 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38712838 JRNL DOI 10.1021/ACS.JMEDCHEM.4C00220 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 31755 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1589 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.9900 - 3.7800 1.00 2933 155 0.1793 0.2241 REMARK 3 2 3.7800 - 3.0000 1.00 2798 147 0.2045 0.2751 REMARK 3 3 3.0000 - 2.6200 1.00 2757 145 0.2281 0.2967 REMARK 3 4 2.6200 - 2.3800 1.00 2731 144 0.2235 0.2337 REMARK 3 5 2.3800 - 2.2100 1.00 2726 144 0.2545 0.3074 REMARK 3 6 2.2100 - 2.0800 1.00 2730 144 0.2345 0.2771 REMARK 3 7 2.0800 - 1.9800 1.00 2705 142 0.2542 0.3101 REMARK 3 8 1.9800 - 1.8900 1.00 2680 141 0.3250 0.3525 REMARK 3 9 1.8900 - 1.8200 1.00 2706 143 0.3125 0.3553 REMARK 3 10 1.8200 - 1.7500 1.00 2700 142 0.3201 0.3432 REMARK 3 11 1.7500 - 1.7000 1.00 2700 142 0.3475 0.4059 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.252 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.75 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2169 REMARK 3 ANGLE : 0.779 2945 REMARK 3 CHIRALITY : 0.050 315 REMARK 3 PLANARITY : 0.008 374 REMARK 3 DIHEDRAL : 19.650 807 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8TU3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000276574. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAY-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31800 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BIS-TRIS PH 6.5, AMMONIUM TARTRATE, REMARK 280 PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.21500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.30500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.21500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.30500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 377 REMARK 465 PRO A 378 REMARK 465 LEU A 379 REMARK 465 GLY A 380 REMARK 465 SER A 381 REMARK 465 LYS A 382 REMARK 465 ASN A 383 REMARK 465 ALA A 384 REMARK 465 PRO A 385 REMARK 465 SER A 386 REMARK 465 THR A 387 REMARK 465 ALA A 388 REMARK 465 GLY A 389 REMARK 465 LEU A 390 REMARK 465 GLY A 391 REMARK 465 TYR A 392 REMARK 465 GLY A 393 REMARK 465 ASP A 548 REMARK 465 ASP A 549 REMARK 465 GLU A 550 REMARK 465 TYR A 551 REMARK 465 THR A 552 REMARK 465 SER A 553 REMARK 465 SER A 554 REMARK 465 VAL A 555 REMARK 465 GLY A 556 REMARK 465 SER A 557 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 GLN A 412 CG CD OE1 NE2 REMARK 470 VAL A 415 CG1 CG2 REMARK 470 LYS A 433 CG CD CE NZ REMARK 470 GLU A 434 CG CD OE1 OE2 REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 GLN A 467 CG CD OE1 NE2 REMARK 470 ARG A 468 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 LYS A 558 CG CD CE NZ REMARK 470 ARG A 600 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 HIS A 635 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 637 CG CD CE NZ REMARK 470 ASP A 639 CG OD1 OD2 REMARK 470 GLU A 657 CG CD OE1 OE2 REMARK 470 SER A 659 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 481 C17 UEO A 701 2.12 REMARK 500 OE1 GLU A 396 OG1 THR A 465 2.15 REMARK 500 OH TYR A 617 O HOH A 801 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 424 -49.08 -130.67 REMARK 500 LYS A 466 30.04 -85.48 REMARK 500 ARG A 520 -9.20 80.00 REMARK 500 ASP A 521 48.82 -149.54 REMARK 500 REMARK 500 REMARK: NULL DBREF 8TU3 A 382 659 UNP Q06187 BTK_HUMAN 382 659 SEQADV 8TU3 GLY A 377 UNP Q06187 EXPRESSION TAG SEQADV 8TU3 PRO A 378 UNP Q06187 EXPRESSION TAG SEQADV 8TU3 LEU A 379 UNP Q06187 EXPRESSION TAG SEQADV 8TU3 GLY A 380 UNP Q06187 EXPRESSION TAG SEQADV 8TU3 SER A 381 UNP Q06187 EXPRESSION TAG SEQRES 1 A 283 GLY PRO LEU GLY SER LYS ASN ALA PRO SER THR ALA GLY SEQRES 2 A 283 LEU GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP LEU SEQRES 3 A 283 THR PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL SEQRES 4 A 283 VAL LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA SEQRES 5 A 283 ILE LYS MET ILE LYS GLU GLY SER MET SER GLU ASP GLU SEQRES 6 A 283 PHE ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS SEQRES 7 A 283 GLU LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN SEQRES 8 A 283 ARG PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY SEQRES 9 A 283 CYS LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG PHE SEQRES 10 A 283 GLN THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS SEQRES 11 A 283 GLU ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS SEQRES 12 A 283 ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN SEQRES 13 A 283 GLY VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR SEQRES 14 A 283 VAL LEU ASP ASP GLU TYR THR SER SER VAL GLY SER LYS SEQRES 15 A 283 PHE PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SEQRES 16 A 283 SER LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY SEQRES 17 A 283 VAL LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO SEQRES 18 A 283 TYR GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE SEQRES 19 A 283 ALA GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER SEQRES 20 A 283 GLU LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU SEQRES 21 A 283 LYS ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER SEQRES 22 A 283 ASN ILE LEU ASP VAL MET ASP GLU GLU SER HET UEO A 701 27 HETNAM UEO 1-[(4R)-4-{[(6P,8S)-6-(1-METHYL-1H-PYRAZOL-4-YL) HETNAM 2 UEO PYRAZOLO[1,5-A]PYRAZIN-4-YL]OXY}AZEPAN-1-YL]PROPAN-1- HETNAM 3 UEO ONE FORMUL 2 UEO C19 H24 N6 O2 FORMUL 3 HOH *79(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 MET A 450 1 13 HELIX 3 AA3 CYS A 481 GLU A 488 1 8 HELIX 4 AA4 MET A 489 ARG A 492 5 4 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 PRO A 560 SER A 564 5 5 HELIX 9 AA9 PRO A 565 SER A 572 1 8 HELIX 10 AB1 SER A 575 SER A 592 1 18 HELIX 11 AB2 THR A 602 GLN A 612 1 11 HELIX 12 AB3 SER A 623 CYS A 633 1 11 HELIX 13 AB4 LYS A 637 ARG A 641 5 5 HELIX 14 AB5 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LEU A 402 THR A 410 0 SHEET 2 AA1 5 VAL A 415 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 PHE A 471 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 3.17 CRYST1 70.430 104.610 38.080 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014198 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009559 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026261 0.00000